Bosch, F. Xavier
Robles, Claudia
Díaz, Mireia
Arbyn, Marc
Baussano, Iacopo
Clavel, Christine
Ronco, Guglielmo
Dillner, Joakim
Lehtinen, Matti
Petry, Karl-Ulrich
Poljak, Mario
Kjaer, Susanne K.
Meijer, Chris J. L. M.
Garland, Suzanne M.
Salmerón, Jorge
Castellsagué, Xavier
Bruni, Laia
de Sanjosé, Silvia
Cuzick, Jack
Article History
First Online: 1 September 2015
Competing interests
: F.X.B., C.R., M.D., X.C., L.B. and S.d.S. have received research funding via their institution from Genticel, GlaxoSmithKline, Merck, Qiagen, Roche, and Sanofi Pasteur MSD. F.X.B. has received reimbursement of travel expenses for attending symposia, meeting and/or conferences from GlaxoSmithKline, Merck, Qiagen, Roche, and Sanofi Pasteur MSD. C.C. has received reimbursement of travel expenses for attending symposia, meeting and/or conferences from Hologic, Roche, and Sanofi Pasteur MSD; and honoraria as a scientific advisory board member from Roche and Sanofi Pasteur MSD. J.D. has received research funding via his institution from Merck and Sanofi Pasteur MSD. K.-U.P. has received research funding via his institution from Sanofi Pasteur MSD; has been an consultant for Becton Dickinson, Roche Diagnostics, and Sanofi Pasteur MSD; and has receiving speakers' honoraria from Becton Dickinson, GlaxoSmithKline, and Roche. M.P. has received reimbursement of travel expenses for attending symposia, meeting and/or conferences, and honoraria for speaking and consultancy from Abbott. S.K.K. has received research funding via her institution, and honorarium as a scientific advisory board member and speaker from Merck and Sanofi Pasteur MSD. C.J.L.M.M. has received research funding from Abbott and Gen-Probe; has minority stock of Diassay and Self-Screen, a spin-off company of the Vrije Universiteit Medical Centre; has held shares in Delphi Biosciences, a former producer of a lavage self-sampling device for cervical cancer screening until 2014, when it went into receivership; has received honoraria from Genticel and Qiagen; has received honoraria occasionally as a scientific advisory board member or for serving at the speakers bureau of GlaxoSmithKline, Qiagen, Roche, and Sanofi Pasteur MSD/Merck; has received honoraria as speaker from Menarini and Seegene; and has received research funding via his institution from GlaxoSmithKline and Sanofi Pasteur MSD. S.M.G. has received research funding via her institution from CSL Bio, GlaxoSmithKline, and Merck; and is a member of the Merck Global Advisory Board and the Merck Scientific Advisory Committee for HPV (unpaid position). X.C. has received reimbursement of travel expenses for attending symposia, meeting and/or conferences from Genticel, GlaxoSmithKline, Merck, Sanofi Pasteur MSD, and Vianex. S.d.S. has received reimbursement of travel expenses for attending symposia, meeting and/or conferences from GlaxoSmithKline, Qiagen, and Sanofi Pasteur MSD. J.C. has received research funding via his institution from Abbott, Beckton Dickinson, Cepheid, Genera, Hologic, Qiagen, and Trovagene; honoraria from Hologic Cepheid, and Merck; and has been on sponsored speakers bureau for Trovagene. M.A., I.B., G.R., M.L. and J.S. declare no competing interests.